NICE TA414: in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation - positive melanoma. (Decision date - Nov 2016).
Do Not Prescribe (DNP) Drug Classifications
6: Have NICE guidance that recommends they should not be used
